Stock & Company Details
Assembly Biosciences Inc $ASMB
Price:
N/A
N/A
20M
$419M
52 Week High:
N/A
10 Day Average Volume:
N/A
-16.17
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ASMB technical indicators
Latest Assembly Biosciences Inc (ASMB) indicator readings as of 2026-10-29.
ASMB's 14-day RSI is 39.6, in neutral territory. At $20.86 it is trading 23.5% below its 200-day moving average of $27.26, and below its 50-day average of $26.41. Price sits in the middle of its Bollinger Bands ($18.79 to $23.65). ADX reads 41.4, indicating a trending market.
Overview
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.
Finance Bot
Ask your questions
Start by typing a question below.
